Filing Details
- Accession Number:
- 0000950170-24-004656
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-16 16:35:45
- Reporting Period:
- 2024-01-10
- Accepted Time:
- 2024-01-16 16:35:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1680367 | Shattuck Labs Inc. | STTK | Pharmaceutical Preparations (2834) | 812575858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1827204 | R Andrew Neill | C/O Shattuck Labs, Inc. 500 W. 5Th Street, Suite 1200 Austin TX 78701 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-10 | 56,500 | $0.00 | 200,916 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-01-10 | 2,470 | $10.09 | 198,446 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2024-01-10 | 25,000 | $10.00 | 173,446 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-01-10 | 113,000 | $0.00 | 113,000 | $10.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 113,000 | 2034-01-10 | No | 4 | A | Direct |
Footnotes
- Consists of 56,500 restricted stock units, which will vest in four equal annual installments beginning on January 10, 2025, subject to the Reporting Person's continued service to the Issuer.
- This option represents a right to purchase a total of 113,000 shares of the Issuer's common stock, one quarter of which will vest on January 10, 2025, with the remaining three quarters vesting in equal monthly installments through January 10, 2028, subject to the Reporting Person's continued service to the Issuer.
Billionaire Hedge Funds
